Literature DB >> 25170038

Foley catheter vs prostaglandin as ripening agent in pregnant women with premature rupture of membranes.

A Dhanya Mackeen1, LaToya Walker2, Kelly Ruhstaller2, Meike Schuster2, Anthony Sciscione2.   

Abstract

CONTEXT: Although studies support the efficacy of the Foley catheter (FC) as a cervical ripening agent in pregnant women at term with intact membranes, its efficacy has not been well studied in women with premature rupture of membranes (PROM).
OBJECTIVE: To compare the interval to delivery in women with PROM who underwent induction of labor and cervical ripening with mechanical (FC) vs nonmechanical (prostaglandin [PG]) cervical ripening agents.
DESIGN: Retrospective medical record review at 2 hospitals of pregnant women who delivered between January 2009 and April 2011.
SETTING: Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, and Christiana Care Health System in Newark, Delaware. PATIENTS: Pregnant women with singleton gestations 36 weeks or greater who presented with PROM.
INTERVENTIONS: Cervical ripening with FC or PG. MAIN OUTCOME MEASURES: The primary outcome was time from induction until delivery. Secondary outcomes included epidural use, maximum temperature during labor, number of vaginal examinations, occurrence of tachysystole, oxytocin dose, delivery mode, chorioamnionitis, and neonatal Apgar score.
RESULTS: Of 155 medical records of patients who met the inclusion criteria, 33 women underwent cervical ripening with PG (ie, misoprostol) and 122 with FC. The interval to delivery was almost halved in women who underwent cervical ripening with FC compared with misoprostol (736 vs 1354 minutes; P<.01). Compared with the women in the misoprostol group, those in the FC group received a statistically significant higher dose of oxytocin (P<.01). There were no statistically significant differences between the groups with respect to the remaining secondary outcomes. Of note, all of the women who received FC were from Christiana Care Health System, and all women who received misoprostol were from Thomas Jefferson University Hospital.
CONCLUSION: Foley catheters may help shorten the interval to delivery in women who are candidates for cervical ripening after PROM at or near term. There does not appear to be an increased risk for cesarean delivery or chorioamnionitis in those treated with FC.
© 2014 The American Osteopathic Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25170038     DOI: 10.7556/jaoa.2014.137

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  5 in total

1.  Induction of labor by Foley catheter compared with spontaneous onset of labor after previous cesarean section: a cohort study.

Authors:  H Kruit; H Wilkman; A Tekay; L Rahkonen
Journal:  J Perinatol       Date:  2017-04-13       Impact factor: 2.521

Review 2.  The Renaissance of Transcervical Balloon Catheters for Cervical Ripening and Labour Induction.

Authors:  W Rath; S Kehl
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

3.  Hygroscopic dilators vs balloon catheter ripening of the cervix for induction of labor in nulliparous women at term: Retrospective study.

Authors:  Ryosuke Shindo; Shigeru Aoki; Naohiro Yonemoto; Yuriko Yamamoto; Junko Kasai; Michi Kasai; Etsuko Miyagi
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

4.  Induction of labour in case of premature rupture of membranes at term with an unfavourable cervix: protocol for a randomised controlled trial comparing double balloon catheter (+oxytocin) and vaginal prostaglandin (RUBAPRO) treatments.

Authors:  Eric Devillard; Amélie Delabaere; Marion Rouzaire; Bruno Pereira; Marie Accoceberry; Céline Houlle; Lydie Dejou-Bouillet; Pamela Bouchet; Denis Gallot
Journal:  BMJ Open       Date:  2019-06-20       Impact factor: 2.692

5.  Double Balloon Catheter (Plus Oxytocin) versus Dinoprostone Vaginal Insert for Term Rupture of Membranes: A Randomized Controlled Trial (RUBAPRO).

Authors:  Eric Devillard; Fanny Petillon; Marion Rouzaire; Bruno Pereira; Marie Accoceberry; Céline Houlle; Lydie Dejou-Bouillet; Pamela Bouchet; Amélie Delabaere; Denis Gallot
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.